4Elnour AA, Mugammar IT, Jaber T, et al. Pharmaceutical care of patients with gestational diabetes mellitus [J] . J Eval Clin Pract, 2008, 14 (1): 131.
5American Academy of Pediatrics Clinical Practice Guideline Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation [ J ] . Pediatrics, 2004, 114 (1):297.
6Sevket O, Ates S, Uysal O, et al. To evaluate the prevalence and clinical outcomes using a one-step method versus a two-step method to screen gestational diabetes meUitus [J]. J Matern Fetal Neonatal Med, 2014,27(1) : 36-41.
7Wery E, Vambergue A, Le Goueff F, et al. Impact of the new screening criteria on the gestational diabetes prevalence [J]. J Gynecol Obstet Biol Reprod (Paris) , 2014,43(4): 307-313.
8Jelsma JG, van Poppel MN, Galjaard S, et al. DALI: Vitamin D and lifestyle intervention for gestational diabetes mellitus ( GDM ) prevention: an European multicentre, randomised trial-study protocol [J]. BMC Pregnancy Childbirth, 2013,13 : 142.
9Feig DS, Hwee J, Shah BR, et al. Trends in incidence of diabetes in pregnancy and serious perinatal outcomes: a large, population-based study in Ontario, Canada, 1996--2010 [J]. Diabetes Care, 2014, 37 (6) : 1590 - 1596.
10Moses RG. Gestational diabetes mellitus: implications of an increased frequency with IADPSG criteria [ J]. Diabetes Care ,2012,35 ( 3 ) : 461 - 462.
